Homeopathy as an adjuvant treatment for patients with COVID-19 Associated Pneumonia

Homeopathy as an adjuvant treatment for patients with COVID-19 - HU/UFSC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-102ydhjs

Enrollment

Unknown

Registered

2022-05-06

Start date

2020-07-13

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Interventions

The study is a two-arm, open-label, randomized clinical trial performed with homeopathic medicines in a public hospital in Brazil. In this country, homeopathy has been an official medical specialty si

Phosphorus (Phos), Bryonia alba (Bry), Camphora (Camph), China officinalis (Chin), Lachesis muta (Lach), Carbo vegetabilis (Carb-v), Suphur (Sulph), Kalium carbonicum (Kali-c), Veratrum album (Verat),

and prescribed at 30cH or 200cH potency.10 We also used a combination of Arsenicum 12cH/Ferrum phosphoricum 6cH/Bryonia 30cH/China officinalis 30cH. The homeopathic medicines were prepared according t

HP3.040

Eligibility

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Both genders; age between 20 and 70 years; positive test for SARS-CoV-2 by reverse transcription polymerase chain reaction or rapid antigen test; pneumonia, diagnosed according to clinical criteria, with or without imaging confirmation (plain radiographs, computed tomography angiography); Indication of hospital admission; no clinical condition that impairs verbal communication; homeopathy interview within 24 hours of admission.

Exclusion criteria

Exclusion criteria: Pregnancy, or women who had given birth up to 45 days earlier; hospital admission for palliative care; lower oxygen saturation 93 percent through an oxygen reservoir mask (criterion for admission to intensive care unit)

Design outcomes

Primary

Measure	Time frame
Evaluate whether the homeopathic intervention reduces or does not change the indication for admission to an intensive care unit, having as relevant variables gender; age; comorbidities; need for oxygen therapy and length of stay.	—

Secondary

Measure	Time frame
To assess whether homeopathic intervention alters the length of stay of patients admitted to the hospital.	—

Countries

Brazil

Contacts

Public ContactRenata Tomazzoni

Universidade Federal de Santa Catarina

renata.tomazzoni@ufsc.br+55 (48) 999717987

Outcome results

None listed

Source: REBEC (via WHO ICTRP)